Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith Sullivan, Daniel E. Furst, Mark H. Wener et al.|New England Journal of Medicine|2018Cited by 584
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C. Townsend, Michelle A. Kelliher, Mark A. Murakami et al.|Cancer Cell|2016Cited by 304
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Marcelo C. Pasquini et al.|Blood|2017Cited by 296
Outcome of Transplantation for MyelofibrosisKaren K. Ballen, Mukta Arora|Biology of Blood and Marrow Transplantation|2009Cited by 265
Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid LeukemiaYi‐Bin Chen, Robert J. Soiffer, Shuli Li et al.|Biology of Blood and Marrow Transplantation|2014Cited by 234